Exelon Forecast, price target & analysts
Exelon Target price 2025 - Analyst rating & recommendation
Exelon Classifications & Recommendation:
Exelon Price Target
| Target Price | $48.96 |
| Price | $47.38 |
| Potential | 3.33% |
| Number of Estimates | 15 |
| 15 Analysts have issued a price target Exelon 2026 . The average Exelon target price is $48.96. This is 3.33% higher than the current stock price. The highest price target is $54.60 15.24% , the lowest is $37.37 21.13% . | |
| A rating was issued by 20 analysts: 10 Analysts recommend Exelon to buy, 8 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Exelon stock has an average upside potential 2026 of 3.33% . Most analysts recommend the Exelon stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2029
15 Analysts have issued a sales forecast Exelon 2025 . The average Exelon sales estimate is $24.3b . This is 2.17% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $25.5b 7.25% , the lowest is $23.0b 3.43% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $23.0b | 5.99% |
|---|---|---|
| 2025 | $24.3b | 5.45% |
| 2026 | $25.0b | 2.90% |
| 2027 | $25.7b | 2.83% |
| 2028 | $26.8b | 4.34% |
| 2029 | $27.8b | 3.57% |
14 Analysts have issued an Exelon EBITDA forecast 2025. The average Exelon EBITDA estimate is $8.9b . This is 6.46% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $9.6b 14.67% , the lowest is $8.4b 0.14% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $7.9b | 5.08% |
|---|---|---|
| 2025 | $8.9b | 12.90% |
| 2026 | $9.6b | 7.70% |
| 2027 | $10.3b | 7.37% |
| 2028 | $10.8b | 5.13% |
| 2029 | $11.5b | 5.88% |
EBITDA Margin
| 2024 | 34.31% | 0.86% |
|---|---|---|
| 2025 | 36.74% | 7.08% |
| 2026 | 38.45% | 4.65% |
| 2027 | 40.14% | 4.40% |
| 2028 | 40.45% | 0.77% |
| 2029 | 41.35% | 2.22% |
18 Exelon Analysts have issued a net profit forecast 2025. The average Exelon net profit estimate is $2.7b . This is 3.50% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.9b 8.33% , the lowest is $2.7b 0.01% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $2.5b | 5.67% |
|---|---|---|
| 2025 | $2.7b | 11.62% |
| 2026 | $2.9b | 4.80% |
| 2027 | $3.1b | 6.49% |
| 2028 | $3.3b | 6.92% |
| 2029 | $3.5b | 7.31% |
Net Margin
| 2024 | 10.68% | 0.30% |
|---|---|---|
| 2025 | 11.31% | 5.87% |
| 2026 | 11.52% | 1.86% |
| 2027 | 11.93% | 3.56% |
| 2028 | 12.22% | 2.43% |
| 2029 | 12.66% | 3.60% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
18 Analysts have issued a Exelon forecast for earnings per share. The average Exelon EPS is $2.72 . This is 3.42% higher than earnings per share in the financial year 2024. The highest EPS forecast is $2.85 8.37% , the lowest is $2.63 0.00% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $2.45 | 4.70% |
|---|---|---|
| 2025 | $2.72 | 11.02% |
| 2026 | $2.85 | 4.78% |
| 2027 | $3.03 | 6.32% |
| 2028 | $3.24 | 6.93% |
| 2029 | $3.48 | 7.41% |
P/E ratio
| Current | 18.02 | 9.70% |
|---|---|---|
| 2025 | 17.43 | 3.25% |
| 2026 | 16.63 | 4.59% |
| 2027 | 15.62 | 6.07% |
| 2028 | 14.60 | 6.53% |
| 2029 | 13.61 | 6.78% |
Based on analysts' sales estimates for 2025, the Exelon stock is valued at an EV/Sales of 3.95 and an P/S ratio of 1.97 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 4.04 | 8.60% |
|---|---|---|
| 2025 | 3.95 | 2.17% |
| 2026 | 3.84 | 2.82% |
| 2027 | 3.74 | 2.75% |
| 2028 | 3.58 | 4.16% |
| 2029 | 3.46 | 3.45% |
P/S ratio
| Current | 2.01 | 15.59% |
|---|---|---|
| 2025 | 1.97 | 2.13% |
| 2026 | 1.92 | 2.82% |
| 2027 | 1.86 | 2.75% |
| 2028 | 1.78 | 4.16% |
| 2029 | 1.72 | 3.45% |
Current Exelon Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Neutral
➜
Neutral
|
Unchanged | Oct 10 2025 |
| Evercore ISI Group |
➜
Outperform
|
Initiated | Oct 07 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Sep 25 2025 |
| Keybanc |
Underweight
➜
Underweight
|
Unchanged | Jul 16 2025 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Jul 11 2025 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Jun 02 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | May 22 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Oct 10 2025 |
|
Initiated
Evercore ISI Group:
➜
Outperform
|
Oct 07 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Sep 25 2025 |
|
Unchanged
Keybanc:
Underweight
➜
Underweight
|
Jul 16 2025 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Jul 11 2025 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Jun 02 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
May 22 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
